High efficacy of sequential chemotherapy (CT) with dose-dense modified TCF regimen (TCF-DD) followed by CT with oxaliplatin, folinic acid (FA), 5-fluorouracil (5-FU) and irinotecan (COFFI) in metastatic gastric cancer (MGC)

被引:0
|
作者
Dalla Chiesa, M. [1 ]
Tomasello, G. [1 ]
Buti, S. [1 ]
Negri, F. [1 ]
Brighenti, M. [1 ]
Lazzarelli, S. [1 ]
Auzzani, A. [1 ]
Curti, A. [1 ]
Martinotti, M. [1 ]
Passalacqua, R. [1 ]
机构
[1] Azienda Ist Ospitalleri Cremona, Cremona, Italy
关键词
D O I
10.1200/jco.2008.26.15_suppl.4570
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4570
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II trial
    Matteo Dalla Chiesa
    Gianluca Tomasello
    Sebastiano Buti
    Rodrigo Kraft Rovere
    Matteo Brighenti
    Silvia Lazzarelli
    Gianvito Donati
    Rodolfo Passalacqua
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 41 - 48
  • [2] Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II trial
    Dalla Chiesa, Matteo
    Tomasello, Gianluca
    Buti, Sebastiano
    Rovere, Rodrigo Kraft
    Brighenti, Matteo
    Lazzarelli, Silvia
    Donati, Gianvito
    Passalacqua, Rodolfo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (01) : 41 - 48
  • [3] Dose-dense chemotherapy (CT with modified TCF regimen (TCF-DD) in metastatic gastric cancer (MGC): A Phase II study
    Dalla Chiesa, M.
    Tomasello, G.
    Buti, S.
    Negri, F.
    Buononato, M.
    Longarini, R.
    Porzio, R.
    Lazzarelli, S.
    Brighenti, M.
    Passalacqua, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] Dose-dense chemotherapy (CT) with modified TCF regimen (TCF-DD) in metastatic gastric cancer (MGC): A phase II study
    Chiesa, M. Dalla
    Tomasello, G.
    Buti, S.
    Negri, F.
    Buononato, M.
    Longarini, R.
    Lazzarelli, S.
    Brighenti, M.
    Passalacqua, R.
    ANNALS OF ONCOLOGY, 2007, 18 : 4 - 4
  • [5] Dose-dense chemotherapy (CT) with modified dose-dense TCF regimen (TCF-dd) in metastatic gastric cancer (MGC): Update of a phase II study
    Dalla Chiesa, M.
    Poli, R.
    Tomasello, G.
    Lazzarelli, S.
    Buti, S.
    Brighenti, M.
    Negri, F.
    Curti, A.
    Auzzani, A.
    Passalacqua, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Dose-dense chemotherapy with modified TCF regimen (TCF-DD) in metastatic gastric cancer (MGC): A feasibility study
    Dalla, Chiesa M.
    Tomasello, G.
    Buti, S.
    Negri, F.
    Buononato, M.
    Lazzarelli, S.
    Donati, G.
    ANNALS OF ONCOLOGY, 2006, 17 : 92 - 92
  • [7] EFFICACY AND SAFETY OF DOSE-DENSE CHEMOTHERAPY WITH MODIFIED TCF REGIMEN (TCF-DD) IN ELDERLY PATIENTS WITH METASTATIC GASTRIC CANCER (MGC)
    Tomasello, G.
    Liguigli, W.
    Lazzarelli, S.
    Poli, R.
    Negri, F. M.
    Toppo, L.
    Ratti, M.
    Brighenti, M.
    Gerevini, F.
    Passalacqua, R.
    ANNALS OF ONCOLOGY, 2012, 23 : 232 - 232
  • [8] Final analysis of efficacy and safety of dose-dense chemotherapy with modified TCF regimen (TCF-dd) in elderly patients (pts) with metastatic gastric cancer (MGC)
    Tomasello, Gianluca
    Liguigli, Wanda
    Poll, Rossana
    Ratti, Margherita
    Toppo, Laura
    Brighenti, Matteo
    Maltese, Mariangela
    Perrucci, Bruno
    Panni, Stefano
    Negri, Federica
    Lazzarelli, Silvia
    Colombi, Chiara
    Curti, Alessandra
    Donini, Maddalena
    Martinotti, Mario
    Rovatti, Massimo
    Passalacqua, Rodolfo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] Phase II study of chemotherapy with oxaliplatin (Ox), irinotecan (Ir), levo-folinic acid (L-FA) and 5-fluorouracil (5-FU) (COFFI) in metastatic gastric cancer (MGC)
    Chiesa, M. Dalla
    Buti, S.
    Tomasello, G.
    Negri, F.
    Donati, G.
    Cattaneo, M.
    Gnocchi, N.
    Bozzetti, R.
    Buononato, M.
    Passalacqua, R.
    ANNALS OF ONCOLOGY, 2005, 16 : 52 - 52
  • [10] Efficacy and safety of dose-dense modified TCF regimen (TCF-dd) in metastatic or locally advanced gastroesophageal cancer (GEC)
    Toppo, Laura
    Tomasello, Gianluca
    Liguigli, Wanda
    Ratti, Margherita
    Poli, Rossana
    Negri, Federica
    Curti, Alessandra
    Vismarra, Marco
    Maltese, Mariangela
    Delfrate, Roberto
    Donini, Maddalena
    Colombi, Chiara
    Brighenti, Matteo
    Panni, Stefano
    Perrucci, Bruno
    Lazzarelli, Silvia
    Passalacqua, Rodolfo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)